Charlie Harris (@charlieharris01) 's Twitter Profile
Charlie Harris

@charlieharris01

AI for Drug Discovery + Biotech | PhD @Cambridge_Uni | Prev @benevolent_ai and biochem @imperialcollege | Glider Pilot

ID: 360863135

linkhttp://cch1999.github.io calendar_today23-08-2011 21:51:40

624 Tweet

1,1K Followers

861 Following

Google DeepMind (@googledeepmind) 's Twitter Profile Photo

We’re presenting AlphaProteo: an AI system for designing novel proteins that bind more successfully to target molecules. 🧬 It could help scientists better understand how biological systems function, save time in research, advance drug design and more. 🧵 dpmd.ai/3XuMqbX

Simon Barnett (@simondbarnett) 's Twitter Profile Photo

There are over 500 amino acids. Also known as non-standard, non-canonical, or even unnatural, these amino acids have diverse functions in Nature and appear to be imbuing therapies with superior physiochemical properties. Read more in my newest essay. tinyurl.com/3apurs2r

There are over 500 amino acids. 

Also known as non-standard, non-canonical, or even unnatural, these amino acids have diverse functions in Nature and appear to be imbuing therapies with superior physiochemical properties. 

Read more in my newest essay.

tinyurl.com/3apurs2r
Joshua Meier (@joshim5) 's Twitter Profile Photo

We’re excited to introduce @ChaiDiscovery and release Chai-1, a foundation model for molecular structure prediction that performs at the state-of-the-art across a variety of drug discovery tasks We're releasing inference code, weights & a web interface: chaidiscovery.com/blog/introduct…

We’re excited to introduce @ChaiDiscovery and release Chai-1, a foundation model for molecular structure prediction that performs at the state-of-the-art across a variety of drug discovery tasks

We're releasing inference code, weights & a web interface: chaidiscovery.com/blog/introduct…
Zavain Dar (@zavaindar) 's Twitter Profile Photo

Today we’re launching Chai Discovery, led by Joshua Meier & his polymathic world class cofounders. We’re also open sourcing Chai-1: a state of the art frontier model for biomolecular interactions. DIMENSION has co-led the founding round alongside Thrive & OpenAI

Today we’re launching <a href="/chaidiscovery/">Chai Discovery</a>, led by <a href="/joshim5/">Joshua Meier</a> &amp; his polymathic world class cofounders. We’re also open sourcing Chai-1: a state of the art frontier model for biomolecular interactions. <a href="/_DimensionCap/">DIMENSION</a> has co-led the founding round alongside Thrive &amp; OpenAI
Imperial College Computational Biology Society (@imperialbiology) 's Twitter Profile Photo

Welcome to everyone joining us in 24/25!🎉🎉🎉 📍Stay tuned to this page for talks, workshops, journal clubs, and many other exciting events! 🥳 We look forward to meeting you at Fresher’s Fair and in the upcoming academic year!

Welcome to everyone joining us in 24/25!🎉🎉🎉

📍Stay tuned to this page for talks, workshops, journal clubs, and many other exciting events!
🥳 We look forward to meeting you at Fresher’s Fair and in the upcoming academic year!
Charlie Harris (@charlieharris01) 's Twitter Profile Photo

Confused by the number of open-sourced AlphaFold3 alternatives recently put out on the market? So was I - so I wrote a little thing about it! Link below 👇

Confused by the number of open-sourced AlphaFold3 alternatives recently put out on the market?

So was I - so I wrote a little thing about it!

Link below 👇
Chaitanya K. Joshi (@chaitjo) 's Twitter Profile Photo

Summary of AF3 reproductions: harrisbio.substack.com/p/the-race-to-… There are a few 'AI for Science' areas that are becoming like LLMs: - Convergence towards methodologies - Big tech, startups, academia (?) pushing each other with each release - Social media traction also very important?

Charlie Harris (@charlieharris01) 's Twitter Profile Photo

Honoured to see my article on AF3 models featured in R&D World alongside GPT-4o1 yesterday...they even seem to think I have a PhD already 🤣 rdworldonline.com/this-week-in-a… [insert science policy imposter syndrome here]

Tom Westgarth (@tom_westgarth15) 's Twitter Profile Photo

Michael Bronstein, Oxford prof + one of the world’s leading experts in protein design, has been given £150mn to set up an AI for biodesign lab in Austria The US equivalent (IPD) has spun out billions of $ Why hasn’t the U.K. backed Michael (or someone like him) to do the same?